NCT04986085 2025-03-28
NUTRIGETNE
Grupo Espanol de Tumores Neuroendocrinos
Completed
Clinical Trials
5 trialsNCT06253897 2024-12-24
BackSOM
Ipsen
Completed
NCT01423734 2023-01-23
The Reproducibility Of Diffusion Weighted Magnetic Resonance Imaging For Neuroendocrine Tumor Liver Metastases
Memorial Sloan Kettering Cancer Center
Completed
NCT02948946 2021-08-04
Clinical Utility Assay as a Biomarker for Gastroenteropancreatic and Lung Neuroendocrine Tumors
H. Lee Moffitt Cancer Center and Research Institute
Completed
NCT03017690 2018-12-21
Lanreotide and Octreotide Long Acting Release (LAR) for Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)
Ipsen
Completed